Search
Showing results for "aboriginal respiratory"
News & Events
New funding to support innovative research projectsTwo The Kids Research Institute Australia research teams have been awarded more than $3.5 million to fund innovative projects.
Research
Lung function in African infants: A pilot studyUnsedated infant lung function measures of tidal breathing, MBW, and eNO are feasible in a semi-rural African setting
Research
Evaluating hypoxia during air travel in healthy infantsUp to a third of ex-preterm infants flying near term exhibit pulse oxygen saturation (SpO2) of less than 85% during air travel.
Research
Survey of clinical infant lung function testing practicesTo evaluate current ILF testing practices and to survey users regarding the indications, limitations and perceived clinical benefits of ILF testing.
Research
Pulmonary diffusing capacity in healthy Caucasian childrenPrevious studies of pulmonary diffusing capacity in children differed greatly in methodologies; numbers of subjects evaluated, and were performed prior to...
Research
The association between Staphylococcus aureus and subsequent bronchiectasis in children with cystic fibrosisDe novo S. aureus acquisition at age 3 is associated with later bronchiectasis and FEF25-75 in children with CF
Research
Normative multiple-breath washout data in school-aged children corrected for sensor errorGraham Kathryn Rachel Alana Hall Ramsey Foong Harper BAppSci PhD CRFS FANZSRS FThorSoc FERS BSc (Hons), PhD BSc (hons), PhD, MBiostat BSc (hons)
Research
Personalised, machine learning based prediction of asthma in childrenThis study aims to show that asthma and allergies in individuals can be predicted before it occurs based on individual family history and information on the early environment.
Research
Geographic consistency in dominant, non-typeable Haemophilus influenzae genotypes colonising four distinct Australian paediatric groups: a cohort studyIdentified dominant PCR-ribotypes common to geographically disparate Australian paediatric populations
Research
Biomarkers to define the treatment end-point for pulmonary exacerbations in cystic fibrosisAdvances in our understanding of early cystic fibrosis lung disease led by the Australian Early Surveillance Team for Cystic Fibrosis (AREST CF) have also indicated the potential utility of a number of biomarkers for monitoring disease severity.